chloroquine has been researched along with Contact Dermatitis in 12 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Itch responses were evoked by histamine, chloroquine, and dinitrochlorobenzene-induced contact dermatitis (CD)." | 3.88 | GPCR Kinase (GRK)-2 Is a Key Negative Regulator of Itch: l-Glutamine Attenuates Itch via a Rapid Induction of GRK2 in an ERK-Dependent Way. ( Han, MK; Im, SY; Im, YN; Kim, HK; Lee, HK; Lee, YD; Park, JS; Song, HR, 2018) |
| "Oxazolone sensitivity was induced by applying 0." | 1.26 | Effect of selected immunoregulatory agents on low-grade contact sensitivity. ( Griswold, DE; Walz, DT, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Im, YN | 1 |
| Lee, YD | 1 |
| Park, JS | 1 |
| Kim, HK | 1 |
| Im, SY | 1 |
| Song, HR | 1 |
| Lee, HK | 1 |
| Han, MK | 1 |
| CHRISTIANSEN, JV | 1 |
| BRODTHAGEN, H | 1 |
| CAHN, MM | 1 |
| LEVY, EJ | 1 |
| SHAFFER, B | 1 |
| POMERANZ, JR | 1 |
| SMITH, EW | 1 |
| MALAK, JA | 1 |
| HERRMANN, WP | 1 |
| SCHULZ, KH | 1 |
| Kellett, JK | 1 |
| Beck, MH | 1 |
| Pathak, MA | 1 |
| Griswold, DE | 1 |
| Walz, DT | 1 |
| Yokozeki, H | 1 |
| Katayama, I | 1 |
| Nishioka, K | 1 |
| Woods, GM | 1 |
| Henderson, KG | 1 |
| Qu, M | 1 |
| Muller, HK | 1 |
| Gieldanowski, J | 1 |
| Pelczarska, A | 1 |
1 review available for chloroquine and Contact Dermatitis
| Article | Year |
|---|---|
Sunscreens: topical and systemic approaches for protection of human skin against harmful effects of solar radiation.
Topics: 5-Methoxypsoralen; Administration, Oral; Administration, Topical; beta Carotene; Carotenoids; Chloro | 1982 |
11 other studies available for chloroquine and Contact Dermatitis
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
GPCR Kinase (GRK)-2 Is a Key Negative Regulator of Itch: l-Glutamine Attenuates Itch via a Rapid Induction of GRK2 in an ERK-Dependent Way.
Topics: Animals; Cell Line; Chloroquine; Dermatitis, Contact; Dinitrochlorobenzene; Disease Models, Animal; | 2018 |
The treatment of polymorphic light eruptions with chloroquine.
Topics: Chloroquine; Dermatitis, Contact; Humans; Skin | 1956 |
The use of amodiaquin (camoquin) in the treatment of polymorphous light eruption.
Topics: Amodiaquine; Antimalarials; Chloroquine; Dermatitis, Contact; Humans; Skin Diseases; Sunlight | 1958 |
STUDIES ON THE MODE OF ACTION OF CHLOROQUINE.
Topics: Anaphylaxis; Cartilage; Chloroquine; Dermatitis; Dermatitis, Contact; Glycosaminoglycans; Granuloma; | 1963 |
[ALLERGIC CONTACT ECZEMA CAUSED BY RESOCHIN].
Topics: Chloroquine; Dermatitis; Dermatitis, Allergic Contact; Dermatitis, Contact; Quinacrine; Skin Tests; | 1965 |
Contact sensitivity to chloroquine sulphate.
Topics: Adolescent; Chloroquine; Dermatitis, Contact; Dermatitis, Occupational; Drug Industry; Humans; Male | 1984 |
Effect of selected immunoregulatory agents on low-grade contact sensitivity.
Topics: Adjuvants, Immunologic; Animals; Chloroquine; Dermatitis, Contact; Dose-Response Relationship, Drug; | 1982 |
Experimental study for the development of an in vitro test for contact allergens. 1. Primary activation of hapten-specific T cells by hapten-conjugated epidermal cells.
Topics: Adrenal Cortex Hormones; Allergens; Animals; Antigen Presentation; Cell Division; Cell Line; Chloroq | 1995 |
Processing of complex antigens and simple hapten-like molecules by epidermal Langerhans cells.
Topics: Animals; Antigen Presentation; Chloroquine; Cycloheximide; Cytochalasin B; Dermatitis, Contact; Fema | 1995 |
Mediators and nonsteroid antiinflammatory drugs in immunologically specific and nonspecific inflammatory processes.
Topics: Adjuvants, Immunologic; Aminopyrine; Animals; Anti-Inflammatory Agents; Arthritis; Bradykinin; Chlor | 1971 |